Detailansicht

Wissensnetz

Person

Matthias Preusser (1976-)

Arzt

Name	Matthias Preusser
Zeit	1976- (Lebensdaten)
Ort	Wien (Wirkungsort) Mödling (Geburtsort) Österreich Deutschland
Geschlecht	männlich
Akademischer Grad bzw. Titel	Univ.-Prof. Dr. med.
Beruf	Arzt (charakteristischer Beruf)
Variante	M. Preusser
Beziehung	Universität Heidelberg. Pathologisches Institut Universitätsklinik für Innere Medizin I (Wien)
Weitere Angaben	Oberarzt an der Universitätsklinik für Innere Medizin I, Klinische Abteilung für Onkologie,Medizinische Universität Wien
Quelle	Wikipedia: https://de.wikipedia.org/w/index.php?title=Matthias_Preusser&oldid=206209217 (Stand: 19.08.2021) OBV: https://permalink.obvsg.at/AC15666437 (Stand: 07.01.2021)
Datensatztyp	Person
GND-Nummer	1156333008
Datensatz-ID	1156333008
Beteiligt an alle anzeigen Joint EANM/EANO/RANO/SNMMI practice guideline/procedure standards for diagnostics and therapy (theranostics) of meningiomas using radiolabeled somatostatin receptor ligands: version 1.0 Lomustine with or without reirradiation for first progression of glioblastoma, LEGATO, EORTC-2227-BTG: study protocol for a randomized phase III study IDH inhibition in gliomas: from preclinical models to clinical trials Clinical characteristics, treatment, and outcome of patients with large cell neuroendocrine carcinoma of the lung and brain metastases – data from a tertiary care center Cellular and humoral responses to fourth SARS-CoV-2 vaccination in a real-life cohort of patients with cancer Systemic inflammatory biomarkers as prognostic tools in patients with gastroesophageal adenocarcinoma Clinical characteristics, treatment, and long-term outcome of patients with brain metastases from thyroid cancer Brain metastases from hepatopancreatobiliary malignancies Emerging systemic treatment options in meningioma Somatostatin analogues in treatment-refractory meningioma: a systematic review with meta-analysis of individual patient data Trastuzumab deruxtecan in HER2-positive breast cancer with brain metastases: a single-arm, phase 2 trial Dermatitis linearis outbreak associated with Paederus balcanicus in Austria Development of an updated, standardized, patient-centered outcome set for lung cancer Innere Medizin - Symptome und klinische Probleme : Block 27 und Tertial Innere Medizin im Klinisch-Praktischen Jahr Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie : 7.-10. Oktober 2022, Wien : abstracts SARS-CoV-2 screening in cancer outpatients during the second wave of the COVID-19 pandemic : Conclusions for crisis response at a high-volume oncology center Prognostic factors in adult brainstem glioma: a tertiary care center analysis and review of the literature Circulating PD-L1 levels change during bevacizumab-based treatment in recurrent glioma LAG-3 expression in the inflammatory microenvironment of glioma Development of randomized trials in adults with medulloblastoma - the example of EORTC 1634-BTG/NOA-23 EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood Interruption of vascular endothelial growth factor receptor 2 signaling induces a proliferative pulmonary vasculopathy and pulmonary hypertension CDKN2A/B homozygous deletion is associated with early recurrence in meningiomas Clinical characteristics and comparison of the outcome in young versus older patients with upper gastrointestinal carcinoma PD-L1 and HER2 Expression in Gastroesophageal Cancer: a Matched Case Control Study Clinical characteristics and prognostic factors of adult patients with pilocytic astrocytoma Modification of preoperative radiochemotherapy for esophageal cancer (CROSS protocol) is safe and efficient with no impact on surgical morbidity Assessment of brain delivery of a model ABCB1/ABCG2 substrate in patients with non-contrast-enhancing brain tumors with positron emission tomography Prognostic assessment in patients with newly diagnosed small cell lung cancer brain metastases: results from a real-life cohort PET/MRI versus PET/CT in oncology: a prospective single-center study of 330 examinations focusing on implications for patient management and cost considerations Noninvasive Differentiation of Meningiomas and Dural Metastases Using Intratumoral Vascularity Obtained by Arterial Spin Labeling Quantitative evidence for early metastatic seeding in colorectal cancer Does neoadjuvant anti-PD1 therapy improve glioblastoma outcome? Brain metastases as first manifestation of advanced cancer: exploratory analysis of 459 patients at a tertiary care center Chordoid meningiomas can be sub-stratified into prognostically distinct DNA methylation classes and are enriched for heterozygous deletions of chromosomal arm 2p Temporal muscle thickness is an independent prognostic marker in melanoma patients with newly diagnosed brain metastases Anti-angiogenic therapies in brain metastases Audencel Immunotherapy Based on Dendritic Cells Has No Effect on Overall and Progression-Free Survival in Newly Diagnosed Glioblastoma: A Phase II Randomized Trial Innere Medizin - Symptome und klinische Probleme : MCW 27 und Tertial innere Medizin im klinisch-praktischen Jahr Recent advances in the biology and treatment of brain metastases of non-small cell lung cancer: summary of a multidisciplinary roundtable discussion Review of cancer treatment with immune checkpoint inhibitors : Current concepts, expectations, limitations and pitfalls Expression of Programmed Cell Death Protein 1 by Tumor-Infiltrating Lymphocytes and Tumor Cells is Associated with Advanced Tumor Stage in Patients with Esophageal Adenocarcinoma Targeted Therapies for Melanoma Brain Metastases Milestones of the last 10 years : CNS cancer Survival prediction using temporal muscle thickness measurements on cranial magnetic resonance images in patients with newly diagnosed brain metastases Tumor-infiltrating lymphocyte subsets and tertiary lymphoid structures in pulmonary metastases from colorectal cancer Local image variance of 7 Tesla SWI is a new technique for preoperative characterization of diffusely infiltrating gliomas: correlation with tumour grade and IDH1 mutational status Dura mater is a potential source of Aβ seeds Optionen für die Behandlung von Hirnmetastasen Innere Medizin - Symptome und klinische Probleme : MCW 27 und Tertial Innere Medizin im klinisch-praktischen Jahr

Hinweis

Die Betaversion beinhaltet noch nicht alle Funktionen und Informationen des Katalogs des DNB-Portals. Falls Sie Informationen vermissen oder ein Medium bestellen wollen, besuchen Sie bitte die entsprechende Seite im Katalog des DNB-Portals über folgenden Link:

Katalog der Deutschen Nationalbibliothek

Matthias Preusser (1976-)

Joint EANM/EANO/RANO/SNMMI practice guideline/procedure standards for diagnostics and therapy (theranostics) of meningiomas using radiolabeled somatostatin receptor ligands: version 1.0

Lomustine with or without reirradiation for first progression of glioblastoma, LEGATO, EORTC-2227-BTG: study protocol for a randomized phase III study

IDH inhibition in gliomas: from preclinical models to clinical trials

Clinical characteristics, treatment, and outcome of patients with large cell neuroendocrine carcinoma of the lung and brain metastases – data from a tertiary care center

Cellular and humoral responses to fourth SARS-CoV-2 vaccination in a real-life cohort of patients with cancer

Systemic inflammatory biomarkers as prognostic tools in patients with gastroesophageal adenocarcinoma

Clinical characteristics, treatment, and long-term outcome of patients with brain metastases from thyroid cancer

Brain metastases from hepatopancreatobiliary malignancies

Emerging systemic treatment options in meningioma

Somatostatin analogues in treatment-refractory meningioma: a systematic review with meta-analysis of individual patient data

Trastuzumab deruxtecan in HER2-positive breast cancer with brain metastases: a single-arm, phase 2 trial

Dermatitis linearis outbreak associated with Paederus balcanicus in Austria

Development of an updated, standardized, patient-centered outcome set for lung cancer

Innere Medizin - Symptome und klinische Probleme : Block 27 und Tertial Innere Medizin im Klinisch-Praktischen Jahr

Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie : 7.-10. Oktober 2022, Wien : abstracts

SARS-CoV-2 screening in cancer outpatients during the second wave of the COVID-19 pandemic : Conclusions for crisis response at a high-volume oncology center

Prognostic factors in adult brainstem glioma: a tertiary care center analysis and review of the literature

Circulating PD-L1 levels change during bevacizumab-based treatment in recurrent glioma

LAG-3 expression in the inflammatory microenvironment of glioma

Development of randomized trials in adults with medulloblastoma - the example of EORTC 1634-BTG/NOA-23

EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood

Interruption of vascular endothelial growth factor receptor 2 signaling induces a proliferative pulmonary vasculopathy and pulmonary hypertension

CDKN2A/B homozygous deletion is associated with early recurrence in meningiomas

Clinical characteristics and comparison of the outcome in young versus older patients with upper gastrointestinal carcinoma

PD-L1 and HER2 Expression in Gastroesophageal Cancer: a Matched Case Control Study

Clinical characteristics and prognostic factors of adult patients with pilocytic astrocytoma

Modification of preoperative radiochemotherapy for esophageal cancer (CROSS protocol) is safe and efficient with no impact on surgical morbidity

Assessment of brain delivery of a model ABCB1/ABCG2 substrate in patients with non-contrast-enhancing brain tumors with positron emission tomography

Prognostic assessment in patients with newly diagnosed small cell lung cancer brain metastases: results from a real-life cohort

PET/MRI versus PET/CT in oncology: a prospective single-center study of 330 examinations focusing on implications for patient management and cost considerations

Noninvasive Differentiation of Meningiomas and Dural Metastases Using Intratumoral Vascularity Obtained by Arterial Spin Labeling

Quantitative evidence for early metastatic seeding in colorectal cancer

Does neoadjuvant anti-PD1 therapy improve glioblastoma outcome?

Brain metastases as first manifestation of advanced cancer: exploratory analysis of 459 patients at a tertiary care center

Chordoid meningiomas can be sub-stratified into prognostically distinct DNA methylation classes and are enriched for heterozygous deletions of chromosomal arm 2p

Temporal muscle thickness is an independent prognostic marker in melanoma patients with newly diagnosed brain metastases

Anti-angiogenic therapies in brain metastases

Audencel Immunotherapy Based on Dendritic Cells Has No Effect on Overall and Progression-Free Survival in Newly Diagnosed Glioblastoma: A Phase II Randomized Trial

Innere Medizin - Symptome und klinische Probleme : MCW 27 und Tertial innere Medizin im klinisch-praktischen Jahr

Recent advances in the biology and treatment of brain metastases of non-small cell lung cancer: summary of a multidisciplinary roundtable discussion

Review of cancer treatment with immune checkpoint inhibitors : Current concepts, expectations, limitations and pitfalls

Expression of Programmed Cell Death Protein 1 by Tumor-Infiltrating Lymphocytes and Tumor Cells is Associated with Advanced Tumor Stage in Patients with Esophageal Adenocarcinoma

Targeted Therapies for Melanoma Brain Metastases

Milestones of the last 10 years : CNS cancer

Survival prediction using temporal muscle thickness measurements on cranial magnetic resonance images in patients with newly diagnosed brain metastases

Tumor-infiltrating lymphocyte subsets and tertiary lymphoid structures in pulmonary metastases from colorectal cancer

Local image variance of 7 Tesla SWI is a new technique for preoperative characterization of diffusely infiltrating gliomas: correlation with tumour grade and IDH1 mutational status

Dura mater is a potential source of Aβ seeds

Optionen für die Behandlung von Hirnmetastasen

Innere Medizin - Symptome und klinische Probleme : MCW 27 und Tertial Innere Medizin im klinisch-praktischen Jahr